|1.||Ben-Eliyahu, Shamgar: 4 articles (03/2010 - 11/2003)|
|2.||Li, Shengjian: 4 articles (01/2008 - 06/2007)|
|3.||Connolly, Peter J: 4 articles (01/2008 - 06/2007)|
|4.||Middleton, Steven A: 4 articles (01/2008 - 06/2007)|
|5.||Liu, Jingchun: 4 articles (01/2008 - 06/2007)|
|6.||Pulito, Virginia: 4 articles (01/2008 - 06/2007)|
|7.||Chiu, George: 4 articles (01/2008 - 06/2007)|
|8.||Ormiston, T: 4 articles (01/2002 - 01/2001)|
|9.||Salpeter, E: 4 articles (01/2002 - 01/2001)|
|10.||Pitman, Roger K: 3 articles (01/2015 - 01/2002)|
|1.||Hypertension (High Blood Pressure)
10/01/1994 - "These observations may explain the efficacy of antiadrenergic agents in the management of hypertension in these patients."
01/01/2013 - "Clinical implications of the change in glomerular filtration rate with adrenergic blockers in patients with morning hypertension: the Japan morning surge-1 study."
06/01/2008 - "An alpha-adrenergic blocker titrated by self-measured blood pressure recordings lowered blood pressure and microalbuminuria in patients with morning hypertension: the Japan Morning Surge-1 Study."
01/01/1984 - "Clinical trials of adrenergic antagonists in pregnancy hypertension."
09/01/2014 - "It is reasonable to use α-Adrenergic Blockers as the treatment of choice for men with hypertension and BPH."
03/07/2003 - "Recent clinical studies in humans also support the idea that beneficial heart failure treatments, such as beta-adrenergic antagonists, involve improved contractility. "
03/01/2013 - "Is exercise training beneficial for heart failure patients taking β-adrenergic blockers? "
10/16/2007 - "More recently, beta-adrenergic receptor antagonists have been found to provide survival benefits in patients suffering from heart failure, although the efficacy of different beta-blockers varies widely in this condition. "
01/01/1998 - "Beta adrenolytic agents are on focus now because of promising results of small and great clinical trials and wider knowledge about the pathophysiology of congestive heart failure. "
01/01/2004 - "The addition of beta-adrenergic antagonists to the treatment regimen for heart failure has validated the neurohormonal hypothesis and provided much-improved outcomes. "
11/01/1989 - "Previously reported data document that efficacy of beta-adrenergic antagonists in lowering mortality rates after acute myocardial infarction. "
08/01/1985 - "Diabetic patients surviving the acute phase of myocardial infarction have a lower survival in follow-up than nondiabetic survivors, although some improvement in survival has been noted following beta-adrenergic-blocker therapy."
05/01/1984 - "Recent results obtained from large clinical trials demonstrate that long-term administration of beta-adrenergic antagonists to patients following myocardial infarction reduces the incidence of death for as long as two years. "
06/01/2012 - "β-Adrenergic receptor antagonists ameliorate myocyte T-tubule remodeling following myocardial infarction."
01/01/2011 - "After acute myocardial infarction, β-adrenergic blockers reduce mortality regardless of patient age. "
|4.||Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/01/2012 - "The alpha-adrenergic receptor antagonists represent the most frequently prescribed first line treatment for benign prostatic hyperplasia. "
05/01/2014 - "This study examined treatment patterns and patient characteristics of men initiating alpha adrenergic blocker therapy (alpha-blocker) for benign prostatic hyperplasia (BPH). "
03/01/1996 - "The present study was undertaken to correlate the rates of the prostatic tissue components and the clinical response to alpha adrenergic blocker in benign prostatic hyperplasia. "
03/01/2015 - "All patients received standardized alpha-adrenergic blocker therapy for the treatment of benign prostatic hyperplasia (BPH) during the run-in period. "
08/01/2013 - "Superselective α-adrenergic blockers versus transurethral resection of the prostate: a prospective comparison of health-related quality of life outcome after treating patients with benign prostatic hyperplasia."
02/01/2004 - "Coronary angiography showed normal coronaries, and the electrocardiographic and echocardiographic changes resolved completely after therapy with an alpha-adrenergic blocker and tumor removal. "
11/01/2015 - "After adequate medical preparation by an α-adrenergic blocker, the tumor was successfully removed by laparoscopy, though the adhesion around the tumor was severe. "
09/01/2011 - "COX inhibitors and β-adrenergic blockers were recently shown to reduce cancer progression in animal models through various mechanisms. "
06/01/1950 - "Observations using adrenolytic drugs and surgery for tumors of the adrenal gland."
01/01/2012 - "Additional investigations that examine β-adrenergic blockers as cancer therapeutics are required to further elucidate this role."
|3.||Adrenergic Antagonists (Antiadrenergic Agents)
|9.||Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
|10.||Sotalol (Sotalol Hydrochloride)
|1.||Coronary Artery Bypass (Coronary Artery Bypass Surgery)
|5.||Drug Therapy (Chemotherapy)